CMPX stock · KR stock

CMPX vs KR

Compass Therapeutics Inc. (CMPX) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.

Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.

Kroger Company (KR) is a grocery stores company listed on US.

CMPX does not have a complete income-statement cache yet.

Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.

CMPX currently screens at market cap $367.4M. KR currently screens at market cap $46.17B and trailing P/E 19.0.

Not investment advice. Open the CMPX and KR stock pages for the full models.

Not investment advice.

Popular Stock Comparisons